Top Markets
Coin of the day
GRAIL Inc. GRAIL Inc.

GRAIL Inc.

GRAL
Classement en actions #4687
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prix de l'action
$79.40
Capitalisation boursière
$3.41B
Changement (1 jour)
-3.80%
Changement (1 an)
133.05%
Pays
US
Échange GRAIL Inc. (GRAL)

Catégorie

EPS pour GRAIL Inc. (GRAL)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de GRAIL Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de GRAIL Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH